Innovating Works

FML

ISOBIOTICS: Isotopic Labeling of Biotherapeutics FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA participó en un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 Biological drugs such as peptides, proteins, oligonucleotides and analogs provide the patients with more efficacious and less toxic treatmen...
2022-07-14 - 2027-01-31 | Financiado
PARC: Partnership for the Assessment of Risks from Chemicals FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA participó en un HORIZON EUROPE: HORIZON-HLTH-2021-ENVHLTH-03 PARC is an EU-wide research and innovation partnership programme to support EU and national chemical risk assessment and risk management bod...
2022-05-24 - 2029-04-30 | Financiado
eMOTIONAL Cities: eMOTIONAL Cities Mapping the cities through the senses of those who make them FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA participó en un H2020: H2020-SC1-BHC-2018-2020 As the world is becoming more urbanized and cities of the future need to be people-centred, robust evidence-based knowledge on the underlyin...
2021-02-02 - 2025-02-28 | Financiado
SLEEP REVOLUTION: Revolution of sleep diagnostics and personalized health care based on digital diagnostics and therap... FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA participó en un H2020: H2020-SC1-BHC-2018-2020 Obstructive sleep apnea (OSA) is associated with various negative health consequences including increased risk of heart disease, hypertensio...
2021-02-01 - 2025-02-28 | Financiado
PHIRI: Population Health Information Research Infrastructure FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA participó en un H2020: A structured European mechanism for COVID-19 exchange to organize and share information between countries is urgently needed, especially in...
2020-12-08 - 2023-10-31 | Financiado
iSTARS: Informatics and Statistics for Advancement of Research Success FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA tramitó un H2020: H2020-WIDESPREAD-2018-2020 With iSTARS, Informatics and Statistical Tools for the Advancement of Research Success, FMUL (School of Medicine at Lisbon University) propo...
2020-06-12 - 2026-12-31 | Financiado
CoroPrevention: Personalized Prevention for Coronary Heart Disease FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA participó en un H2020: H2020-SC1-BHC-2018-2020 European Coronary Heart Disease (CHD) burden is unsustainable. Better risk stratification tools and personalized care of patients are needed...
2019-12-13 - 2026-12-31 | Financiado
LITMUS: Liver Investigation Testing Marker Utility in Steatohepatitis FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, Non-Alcoholic Fatty Liv...
2017-10-09 - 2024-02-29 | Financiado
HBM4EU: European Human Biomonitoring Initiative FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA participó en un H2020: H2020-SC1-2016-2017 The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemi...
2016-12-09 - 2022-06-30 | Financiado
ALHTOUR: ASSISTED LIVING TECHNOLOGIES FOR THE HEALTH TOURISM SECTOR FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA participó en un H2020: H2020-TWINN-2015 The ALHTOUR project aims to strengthen and stimulate scientific excellence, and innovation capacity in technologies for independent living,...
2015-12-04 - 2018-12-31 | Financiado
CARBALIVE: Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of live... FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA participó en un H2020: H2020-PHC-2014-2015 Chronic liver disease affects about 29-million Europeans accounting for about 170,000 deaths at a cost of around €15.8bn. This chronic non-c...
2015-04-07 - 2021-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.